Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders
The book recognizes that throughout the scientific, medical, and economic communities, new tests incorporating biomarkers are needed to improve the diagnosis of patients suffering from metabolic disorders. The early identification of those at risk of developing obesity will help to place these indiv...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
| Edition: | 1st ed. 2019. |
| Series: | Proteomics, Metabolomics, Interactomics and Systems Biology ;
1134 |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- 1. Insulin Resistance in Schizophrenia
- 2. Biogenesis of the Insulin Secretory Granule in Health and Disease
- 3. Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions
- 4. Preclinical Models of Altered Early Life Nutrition and Development of Reproductive Disorders in Female Offspring
- 5. Targeting Mitochondrial Defects to Increase Lngevity in Animal Models of Neurodegenerative Diseases
- 6. Computational Approaches for Identification of Pleiotropic Biomarker Profiles in Psychiatry
- 7. MiRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-Alcoholic Fatty Liver Disease
- 8. Hypercaloric Diet-Induced Obesity and Obesity-Related Metabolic Disorders in Experimental Models
- 9. Metabolic Biomarkers in Nematode C. elegans During Aging
- 10. Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases
- 11. Deciphering Endothelial Dysfunction in the HIV-Infected Population
- 12. The Role of Inflammation in the Development of GDM and The Use of Markers of Inflammation in GDM Screening
- 13. PFKP Signaling at a Glance: an Emerging Mediator of Cancer Cell Metabolism
- 14. ATAD3A on the Path to Cancer
- 15. Impact of Exercise on Inflammatory Mediators of Metabolic and Vascular Insulin Resistance in Type 2 Diabetes.
